Methylphenidate Hydrochloride Extended-Release Capsules (LA), 20 mg, 100 count bottle, Rx only, T...

FDA Drug Recall #D-847-2013 — Class II — June 18, 2013

Recall Summary

Recall Number D-847-2013
Classification Class II — Moderate risk
Date Initiated June 18, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Teva Pharmaceuticals USA, Inc.
Location Sellersville, PA
Product Type Drugs
Quantity 16,293 bottles

Product Description

Methylphenidate Hydrochloride Extended-Release Capsules (LA), 20 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS USA, NDC 0093-5346-01

Reason for Recall

Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.

Distribution Pattern

Nationwide

Lot / Code Information

34010282A, 34010283A, 34010284A, 34010285A, 34010286A and 34010565A, exp 04/14; 34013199A, 34013200A, 34013201A, 34013202A and 34013203A, exp 10/14.

Other Recalls from Teva Pharmaceuticals USA, Inc.

Recall # Classification Product Date
D-0518-2020 Class II Valganciclovir Hydrochloride for Oral Solution,... Nov 4, 2019
D-747-2014 Class III Fluconazole Oral Suspension, 10 mg/mL, 35 ml bo... Nov 14, 2013
D-1061-2014 Class II Valacyclovir Hydrochloride Tablets, 1 g, 30 cou... Nov 8, 2013
D-928-2013 Class II CARBOplatin Injection, 600 mg/60ml, MultiDose, ... Aug 13, 2013
D-924-2013 Class II Propranolol Hydrochloride Tablets, USP, 10 mg, ... Aug 6, 2013

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.